| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -48.45M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CERO returned -99.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -85.1% |
| 1 year | -99.9% |
| All-time high | $22,100.00 (Apr 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CERO would be worth today ›No. CERo Therapeutics Holdings, Inc. has not paid a dividend in the past 12 months.
CERo Therapeutics Holdings, Inc. is part of the Healthcare sector.
CERo Therapeutics Holdings, Inc. has a market cap of 716.31K USD, based on the latest quote.
